These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16104618)

  • 21. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home.
    Joseph J; Koka M; Aronow WS
    J Am Med Dir Assoc; 2008 Feb; 9(2):124-7. PubMed ID: 18261706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
    Corp EV; Antoniou S; Wright PG; Khachi H; Vercaeren S; Wald DS
    QJM; 2009 Dec; 102(12):843-9. PubMed ID: 19828644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002.
    Bennett K; Johnson H; Dack P; Shelley E; Feely J
    Ir J Med Sci; 2005; 174(3):4-8. PubMed ID: 16285330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
    Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication use in long-term survivors from the MONICA/KORA Myocardial Infarction Registry.
    Amann U; Kirchberger I; Heier M; Thilo C; Kuch B; Meisinger C
    Eur J Intern Med; 2018 Jan; 47():62-68. PubMed ID: 28826823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Socioeconomic Factors, Secondary Prevention Medication, and Long-Term Survival After Coronary Artery Bypass Grafting: A Population-Based Cohort Study From the SWEDEHEART Registry.
    Nielsen SJ; Karlsson M; Björklund E; Martinsson A; Hansson EC; Malm CJ; Pivodic A; Jeppsson A
    J Am Heart Assoc; 2020 Mar; 9(5):e015491. PubMed ID: 32114890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medical management of patients with stable coronary artery disease in France in 2004. Data from the Mutualité Sociale Agricole].
    Jeantet M; Gosselin S; Lefrand E; Hunold H; Vanbockstael V; Bertrand D; Danchin N
    Presse Med; 2006; 35(7-8):1123-30. PubMed ID: 16840887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Underuse of cardioprotective medications in patients prior to acute myocardial infarction.
    Miller RR; Li YF; Sun H; Kopjar B; Sales AE; Piñeros SL; Fihn SD
    Am J Cardiol; 2003 Jul; 92(2):209-11. PubMed ID: 12860227
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An intervention to improve secondary prevention of coronary heart disease.
    Bailey TC; Noirot LA; Blickensderfer A; Rachmiel E; Schaiff R; Kessels A; Braverman A; Goldberg A; Waterman B; Dunagan WC
    Arch Intern Med; 2007 Mar; 167(6):586-90. PubMed ID: 17389290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians.
    Ubel PA; Jepson C; Asch DA
    J Gen Intern Med; 2003 Dec; 18(12):977-83. PubMed ID: 14687255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
    Danchin N; Cambou JP; Hanania G; Kadri Z; Genès N; Lablanche JM; Blanchard D; Vaur L; Clerson P; Guéret P;
    Am Heart J; 2005 Dec; 150(6):1147-53. PubMed ID: 16338251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of percutaneous coronary intervention in non ST-elevation acute coronary syndromes on prescription of secondary prevention medications. Data from the S-Témoin Registry].
    Danchin N; Thébaut JF; Diévart F; Grenier O; Mihci E; Herrmann MA; Ferrières J
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):30-5. PubMed ID: 17343036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment after myocardial infarction].
    Beurrier D; Danchin N
    Presse Med; 1994 Feb; 23(8):380-4. PubMed ID: 7911570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 1997-2000.
    Weiss R; Buckley K; Clifford T
    Clin Ther; 2002 Sep; 24(9):1451-62. PubMed ID: 12380636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004.
    Margulis AV; Choudhry NK; Dormuth CR; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1088-97. PubMed ID: 21538672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.